GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Shedir Pharma Group SpA (MIL:SHE) Future 3-5Y EPS without NRI Growth Rate : 7.48 (As of Apr. 13, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate is 7.48.


Competitive Comparison of Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Shedir Pharma Group SpA  (MIL:SHE) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Shedir Pharma Group SpA Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shedir Pharma Group SpA Business Description

Industry
Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines